This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2009 Apr 10;27(11):1737-9.

doi: 10.1200/JCO.2008.20.6292. Epub 2009 Mar 2.

The ordinary miracle of cancer clinical trials

David P Steensma

PMID: 19255310
DOI: 10.1200/JCO.2008.20.6292

Editorial

The ordinary miracle of cancer clinical trials

David P Steensma. J Clin Oncol. 2009.

. 2009 Apr 10;27(11):1737-9.

doi: 10.1200/JCO.2008.20.6292. Epub 2009 Mar 2.

Author

David P Steensma

PMID: 19255310
DOI: 10.1200/JCO.2008.20.6292

No abstract available

PubMed Disclaimer

Comment on

Steps and time to process clinical trials at the Cancer Therapy Evaluation Program.
Dilts DM, Sandler AB, Cheng SK, Crites JS, Ferranti LB, Wu AY, Finnigan S, Friedman S, Mooney M, Abrams J. Dilts DM, et al. J Clin Oncol. 2009 Apr 10;27(11):1761-6. doi: 10.1200/JCO.2008.19.9133. Epub 2009 Mar 2. J Clin Oncol. 2009. PMID: 19255315 Free PMC article.

Similar articles

[An oncologist's point of view on cancer and miracle medicines].
Nordman E. Nordman E. Nord Med. 1985;100(4):120-1. Nord Med. 1985. PMID: 3887325 Clinical Trial. Swedish. No abstract available.
Molecular imaging to select cancer therapy and evaluate treatment response.
Mankoff DA. Mankoff DA. Q J Nucl Med Mol Imaging. 2009 Apr;53(2):181-92. Q J Nucl Med Mol Imaging. 2009. PMID: 19293766 Review.
[Clinical cancer advances: an annual review--2007].
Svoboda M. Svoboda M. Klin Onkol. 2008;21(3):124-6. Klin Onkol. 2008. PMID: 19097422 Czech. No abstract available.
Methodology of superficial bladder cancer trials: objective evaluation of treatment - the need for standardization.
Bassi PF, Volpe A, Racioppi M, D'Agostino D, Gardi M, Totaro A, Pinto F, Sacco E, Bongiovanni L. Bassi PF, et al. Urol Int. 2009;83(3):258-63. doi: 10.1159/000241663. Epub 2009 Oct 13. Urol Int. 2009. PMID: 19829021
Novel therapeutic strategies in prostate cancer: establishing a stratification system for patient selection in targeted trials.
Priolo C, Oh WK, Loda M. Priolo C, et al. IDrugs. 2009 Mar;12(3):165-8. IDrugs. 2009. PMID: 19333896 Review.

See all similar articles

Cited by

Clinical research and the public: if not them, who?
Selker HP. Selker HP. Clin Transl Sci. 2010 Aug;3(4):132-3. doi: 10.1111/j.1752-8062.2010.00215.x. Clin Transl Sci. 2010. PMID: 20718812 Free PMC article. No abstract available.
Cancer drugs in the United States: Justum Pretium--the just price.
Kantarjian HM, Fojo T, Mathisen M, Zwelling LA. Kantarjian HM, et al. J Clin Oncol. 2013 Oct 1;31(28):3600-4. doi: 10.1200/JCO.2013.49.1845. Epub 2013 May 6. J Clin Oncol. 2013. PMID: 23650428 Free PMC article. No abstract available.
Compartmentalized cancer drug discovery targeting mitochondrial Hsp90 chaperones.
Kang BH, Altieri DC. Kang BH, et al. Oncogene. 2009 Oct 22;28(42):3681-8. doi: 10.1038/onc.2009.227. Epub 2009 Aug 3. Oncogene. 2009. PMID: 19648961 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information